<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00570973</url>
  </required_header>
  <id_info>
    <org_study_id>ENDOvsTIPS</org_study_id>
    <nct_id>NCT00570973</nct_id>
  </id_info>
  <brief_title>Band Ligation Versus Transjugular Intrahepatic Portosystemic Stent Shunt (TIPS) in Cirrhotics With Recurrent Variceal Bleeding Non Responding to Medical Therapy</brief_title>
  <acronym>ENDOvsTIPS</acronym>
  <official_title>A Randomized, Controlled, Multicentric Trial Comparing Endoscopic Band Ligation Versus Ransjugular Intrahepatic Portosystemic Stent Shunt in Cirrhotic Patients With Recurrent Variceal Bleeding Non Responding to Medical Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with liver cirrhoses and recent history of variceal bleeding, with HVPG documented
      non response to medical therapy with non selective beta blockers +/- mononitrates or variceal
      rebleeding during adequate medical therapy will be randomized to undergo either multi-session
      endoscopic multi-band ligation and continuation of medication or TIPS placement. Best
      treatment for this group of cirrhotic patients is not known so far.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Reduction of portal pressure are with oral intake of non selective beta blockers, often
      combined with mononitrates are the method of choice in secondary prophylaxis of esophageal
      variceal bleeding. However, studies have shown that this therapy is effective only in 20-50%
      of the patients, documented by a significant drop of the portal pressure with hepatic venous
      pressure (HVPG) measurements. The best method for secondary prevention in this high risk
      patient cohort is not known so far. In this randomized controlled study we hypothesise, that
      a group of 20 vs 20 patients is large enough to discriminate efficacy of prevention of
      rebleeding in patients receiving TIPS implantation or endoscopic band ligation in patients
      non responding to medical therapy as secondary prophylaxis of esophageal variceal bleeding.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2004</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence of Variceal Bleeding</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Survival of Patients</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Gastrointestinal Hemorrhage</condition>
  <condition>Variceal Bleeding</condition>
  <condition>Cirrhosis</condition>
  <condition>Encephalopathy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Endoscopic Band ligation combined with medical therapy (orally, daily administered propranolol and mononitrate)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Transjugular intrahepatic portosystemic stent shunt with PTFE-covered stent</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endoscopic band ligation</intervention_name>
    <description>Endoscopic Band ligation of esophageal varices, performed every 2-4 weeks until resolution of varices</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TIPS-Implantation</intervention_name>
    <description>Transjugular intrahepatic portosystemic stent shunt with PTFE-covered stent, placed once, under fluoroscopic control,</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  liver cirrhosis

          -  bleeding from esophageal varices within the last 6 months

          -  sufficient medical therapy (at least 80 mg propranolol per day)

          -  signed written informed consent

        Exclusion Criteria:

          -  bleeding of gastric varices

          -  portal vein thrombosis

          -  insufficient medical therapy (less than 80 mg propranolol per day)

          -  exclusion criteria for TIPS/band ligation (anatomy, impaired coagulation parameters,
             severe encephalopathy, severe liver failure (bilirubin &gt; 10 mg/dl)) congestive heart
             failure, pulmonary hypertension, polycystic liver disease, presence or suspicion of
             active systemic, biliary or ascitic fluid infection, known cavernous portal vein
             occlusion

          -  Budd Chiari syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnulf Ferlitsch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Internal Medicine IV, Krankenhaus der Elisabethinen Linz</name>
      <address>
        <city>Linz</city>
        <state>Upper Austria</state>
        <zip>4020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of Graz</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept. of Internal Medicine III, Gastroenterology and Hepatology, Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wilhelminenspital der Stadt Wien</name>
      <address>
        <city>Vienna</city>
        <zip>1160</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>May 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2007</study_first_submitted>
  <study_first_submitted_qc>December 10, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2007</study_first_posted>
  <last_update_submitted>May 20, 2011</last_update_submitted>
  <last_update_submitted_qc>May 20, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 23, 2011</last_update_posted>
  <responsible_party>
    <name_title>Arnulf Ferlitsch, MD</name_title>
    <organization>Gastroenterology and Hepatology, Medical University of Vienna</organization>
  </responsible_party>
  <keyword>Variceal Bleeding</keyword>
  <keyword>Cirrhosis</keyword>
  <keyword>Encephalopathy</keyword>
  <keyword>Endoscopic band ligation</keyword>
  <keyword>TIPS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Gastrointestinal Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

